Clinical effects of oral fluoxymesterone in patients with dialysis-controlled uremia.
D000284:Administration, Oral; D000328:Adult; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001803:Blood Transfusion; D001806:Blood Urea Nitrogen; D002470:Cell Survival; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000502:physiology; D004921:Erythropoietin / Q000032:analysis; D005474:Fluoxymesterone / Q000008:administration & dosage* / Q000627:therapeutic use; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000097:blood; D008297:Male; D008875:Middle Aged; D010953:Plasma Volume; D006435:Renal Dialysis; D014280:Triglycerides / Q000097:blood; D014511:Uremia / Q000150:complications / Q000628:therapy*
D006454:Hemoglobins; D014280:Triglycerides; D004921:Erythropoietin; D002784:Cholesterol; D005474:Fluoxymesterone; D003404:Creatinine; D007501:Iron